Page results
-
The plasma exchange service at the National Hospital treats patients with neuroimmunological diseases such as Guillain-Barré syndrome and myasthenia gravis.
-
The UCLH play and youth services team provides therapeutic, diagnostic, developmental and specialised play interventions to help support children and young people during their time at UCLH.
-
The Interventional Oncology Service (IOS) at University College London Hospital (UCLH) is committed to improving the experience and outcomes for patients with cancer through cutting edge image guided interventions.
-
This information is for patients who are having radiotherapy to the pelvis.
-
This is information for women about medical management after an ultrasound diagnosis of a miscarriage.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
We provide effective, evidence-based nutritional assessment, dietary advice, nutritional intervention and support to patients, their carers and all staff involved in patient care. The main aim of this advice is the prevention or correction of nutrition-related symptoms and/or disease.
-
The tissue viability team is committed to providing support, training and education to clinical staff, patients and carers about maintaining, promoting skin integrity and preventing pressure sores.
-
This page is for patients who are receiving radiotherapy to the bladder.
-
Our pain clinics are patient-centred and evidence-based, encouraging patients to self-manage their persistent facial pain.
File results
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments